SEC Info - AbbVie Inc.

SEC Info℠

Home

My Interests

Help

Please Sign In

AbbVie Inc.
IL
SEC # 1551152

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

*As Of*	*Filing*	*Page*	*Title*	*Docs.*

3/18/24	DEF 14A	1	AbbVie Savings Plan	2
		1	About the Meeting	2
2/26/24	424B5	1	About this Prospectus	2
		1	About This Prospectus Supplement	2
3/18/24	DEF 14A	1	Additional Information	2
		1	Anti-Hedging and Anti-Pledging Policies	2
		1	Audit Committee Report	2
		1	Audit Fees and Non-Audit Fees	2
		1	Audit Information	2
2/20/24	10-K	1	Background	1
3/18/24	DEF 14A	1	Base Salary	2
		1	Benefits	2
2/20/24	10-K	1	Bersecurity	1
3/18/24	DEF 14A	1	Board of Directors and Its Committees, The	2
2/20/24	10-K	1	Business	1
3/18/24	DEF 14A	1	Business Performance Highlights	2
		1	C Ompensation Plan Elements	2
2/26/24	424B5	1	Capitalization	2
2/20/24	10-K	1	Certain Relationships and Related Transactions, and Director Independence	1
3/18/24	DEF 14A	1	Change in Control Agreements	2
2/20/24	10-K	1	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure	1
3/18/24	DEF 14A	1	Clawback Policy	2
2/20/24	10-K	1	Collaborations	1
3/18/24	DEF 14A	1	Com pensation Philosophy	2
		1	Commitment to Performance-Based Awards	2
		1	Committee Process for Setting Total Compensation	2
		1	Communicating With the Board of Directors	2
		1	Compensation Benchmarking	2
		1	Compensation Committee Report	2
		1	Compensation Discussion and Analysis	2
		1	Compensation Program Governance Summary	2
		1	Compensation Risk Assessment	2
		1	Compensation Risk Oversight	2
		1	Components of our Compensation Program	2
2/20/24	10-K	1	Consolidated Balance Sheets	1
		1	Consolidated Statements of Cash Flows	1
		1	Consolidated Statements of Comprehensive Income	1
		1	Consolidated Statements of Earnings	1
		1	Consolidated Statements of Equity	1
		1	Controls and Procedures	4
3/18/24	DEF 14A	1	Cost of Soliciting Proxies	2
2/20/24	10-K	1	Debit, Credit Facilities and Commitments and Contingencies	1
2/26/24	424B5	1	Description of Debt Securities	2
		1	Description of Notes	2
3/18/24	DEF 14A	1	Director Compensation	2
2/20/24	10-K	1	Directors, Executive Officers and Corporate Governance	1
		1	Disclosure Regarding Foreign Jurisdictions That Prevent Inspections	1
3/18/24	DEF 14A	1	Discretionary Voting Authority	2
2/20/24	10-K	1	Earnings Per Share	1
3/18/24	DEF 14A	1	Employment Agreements	2
2/20/24	10-K	1	Equity	1
3/18/24	DEF 14A	1	Excise Tax Gross-Ups	2
		1	Executive Compensation	3
		1	Executive Compensation Highlights	2
		1	Executive Compensation Process	2
		1	Executive Summary	2
11/6/23	10-Q	1	Exhibits	3
2/20/24	10-K	1	Exhibits, Financial Statement Schedules	1
2/26/24	424B5	1	Experts	2
6/28/23	11-K	1	Fair value hierarchy under the accounting standard for fair value measurements consists of the following three levels, The	1
11/6/23	10-Q	1	Financial Information	3
2/20/24	10-K	1	Financial Instruments and Fair Value Measures	1
		1	Financial Statements and Supplementary Data	4
		1	Form 10-K Summary	1
2/26/24	424B5	1	Forward-Looking Statements	2
2/20/24	10-K	1	Fourth Quarter Financial Results (unaudited)	1
		1	Goodwill and Intangible Assets	1
		1	Income Taxes	1
2/26/24	424B5	1	Industry and Market Data	2
2/20/24	10-K	1	Information About Our Executive Officers	1
3/18/24	DEF 14A	1	Information About the Annual Meeting	2
		1	Information Concerning Director Nominees	2
2/26/24	424B5	1	Information Incorporated by Reference	2
3/18/24	DEF 14A	1	Inspectors of Election	2
2/20/24	10-K	1	Integration and Restructuring Plans	1
		1	Item 1	4
		1	Item 10	1
		1	Item 11	1
		1	Item 12	1
		1	Item 13	1
		1	Item 14	1
		1	Item 15	1
		1	Item 16	1
		1	Item 1A	1
		1	Item 1B	1
		1	Item 2	4
		1	Item 3	4
		1	Item 4	4
		1	Item 5	3
		1	Item 6	4
		1	Item 7	1
		1	Item 7A	1
		1	Item 8	1
		1	Item 9	1
		1	Item 9A	1
		1	Item 9B	1
		1	Item 9C	1
		1	Leases	1
2/26/24	424B5	1	Legal Matters	2
2/20/24	10-K	1	Legal Proceedings	4
		1	Legal Proceedings and Contingencies	1
		1	Licensing, Acquisitions and Other Arrangements	1
3/18/24	DEF 14A	1	Long-Term Incentives and 2023 Results	2
		1	Management Proposal to Eliminate Supermajority Voting	2
2/20/24	10-K	1	Management's Discussion and Analysis of Financial Condition and Results of Operations	4
		1	Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	1
2/26/24	424B5	1	Material U.S. Federal Income Tax Considerations	2
2/20/24	10-K	1	Mine Safety Disclosures	1
		1	Note 1	1
		1	Note 10	1
		1	Note 11	1
		1	Note 12	1
		1	Note 13	1
		1	Note 14	1
		1	Note 15	1
		1	Note 16	1
		1	Note 17	1
		1	Note 2	1
		1	Note 3	1
		1	Note 4	1
		1	Note 5	1
		1	Note 6	1
		1	Note 7	1
		1	Note 8	1
		1	Note 9	1
6/28/23	11-K	1	Notes to Financial Statements	1
3/18/24	DEF 14A	1	Notice and Access	2
2/20/24	10-K	1	Other Information	4
11/6/23	10-Q	1	Other Items	2
3/18/24	DEF 14A	1	Other Matters	2
		1	Our Business Performance	2
		1	Our ESG Highlig hts	2
		1	Our Governance Highlights	2
2/20/24	10-K	1	Part I	4
		1	Part Ii	4
		1	Part Iii	1
		1	Part Iv	1
2/26/24	424B5	1	Plan of Distribution	2
3/18/24	DEF 14A	1	Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of the Independent Registered Public Accounting Firm	2
2/20/24	10-K	1	Post-Employment Benefits	1
3/18/24	DEF 14A	1	Potential Payments upon Termination or Change in Control	2
2/22/24	S-8	1	Power of Attorney (included in the signature page to this Registration Statement)	1
2/20/24	10-K	1	Principal Accounting Fees and Services	1
		1	Properties	1
2/26/24	424B5	1	Prospectus Summary	2
3/18/24	DEF 14A	1	Proxy Summary	2
2/20/24	10-K	1	Quantitative and Qualitative Disclosures About Market Risk	4
3/18/24	DEF 14A	1	Quorum	2
		1	Ratification of Ernst & Young Llp as Abbvie's Independent Registered Public Accounting Firm	2
2/20/24	10-K	1	Report of Independent Registered Public Accounting Firm	2
		1	Reserved	1
3/18/24	DEF 14A	1	Revoking a Proxy	2
2/26/24	424B5	1	Risk Factors	3
3/18/24	DEF 14A	1	Role of the Compensation Consultant	2
2/26/24	424B5	1	S-1	2
		1	S-13	2
		1	S-17	2
		1	S-18	2
		1	S-2	2
		1	S-20	2
		1	S-36	2
		1	S-41	2
		1	S-48	2
		1	S-49	2
		1	S-50	2
		1	S-51	2
3/18/24	DEF 14A	1	Say on Pay-Advisory Vote on the Approval of Executive Compensation	2
		1	Say When on Pay-Advisory Vote on the Frequency of Future Approvals of Executive Compensation	2
6/28/23	11-K	1	SCHEDULE H, LINE 4i -- SCHEDULE OF ASSETS (HELD AT END OF YEAR)	1
		1	Schedule of Assets (Held at End of Year)	1
3/18/24	DEF 14A	1	Securities Ownership	2
2/20/24	10-K	1	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	1
		1	Segment and Geographic Area Information	1
3/18/24	DEF 14A	1	Short-Term Incentives and 2023 Results	2
2/20/24	10-K	1	Signatures	1
6/28/23	11-K	1	Statement of Changes in Net Assets Available for Benefits	1
		1	Statements of Net Assets Available for Benefits	1
3/18/24	DEF 14A	1	Stock Ownership Guidelines	2
		1	Stockholder Engagement	2
		1	Stockholder Proposal on Lobbying	2
		1	Stockholder Proposal on Patent Process	2
		1	Stockholder Proposal on Simple Majority Vote	2
		1	Stockholder Proposals	2
2/26/24	424B5	1	Summary	2
3/18/24	DEF 14A	1	Summary Compensation Table	2
2/20/24	10-K	1	Summary of Significant Accounting Policies	1
		1	Supplemental Financial Information	1
3/18/24	DEF 14A	1	Table of Contents	4
2/20/24	10-K	1	Tem 1C	1
3/18/24	DEF 14A	1	The Board of Directors and Its Committees	2
6/28/23	11-K	1	The fair value hierarchy under the accounting standard for fair value measurements consists of the following three levels	1
2/26/24	424B5	1	Underwriting (Conflicts of Interest)	2
11/6/23	10-Q	1	Unregistered Sales of Equity Securities and Use of Proceeds	3
2/20/24	10-K	1	Unresolved Staff Comments	1
2/26/24	424B5	1	Use of Proceeds	2
3/18/24	DEF 14A	1	Votes Required for Each Item	2
		1	Voting by Proxy	2
2/26/24	424B5	1	Where to Obtain More Information	2
		1	Where You Can Find More Information	2
3/18/24	DEF 14A	1	Who Can Vote	2
		1	Who We Are	2
2/20/24	10-K	1	(Pcaob Id	1
		1	101	1
		1	102	1
		1	103	1
		1	104	1
		1	108	1
		1	109	1
3/18/24	DEF 14A	1	2023 Grants of Plan-Based Awards	2
		1	2023 Option Exercises and Stock Vested	2
		1	2023 Outstanding Equity Awards at Fiscal Year End	2

↑Top

AbbVie Inc. IL SEC # 1551152

366 Topics within the Past Year Past Two Years Past Three Years Past Four Years Past Five Years Entire Database

AbbVie Inc.
IL
SEC # 1551152

366 Topics
within the